Janzen RW - Search Results

1

Mini-infarct encephalopathy associated with uncommon microvessel convolute formation presenting with presenile dementia.

van de Nes JA, Zimmer R, Janzen RW, Turowski B, Hürtle E, Schlote W. van de Nes JA, et al. Among authors: janzen rw. Clin Neuropathol. 2003 May-Jun;22(3):101-9. Clin Neuropathol. 2003. PMID: 12809352

2

[Carotid stenting--stratification of the acute phase, indications in secondary prevention from the neurological viewpoint]].

Janzen RW. Janzen RW. Z Kardiol. 2000;89 Suppl 8:9-13. Z Kardiol. 2000. PMID: 11149293 German.

3

[Irreversible brain death-Part 2. Spinalization phenomena].

Janzen RWC, Lambeck J, Niesen W, Erbguth F. Janzen RWC, et al. Nervenarzt. 2021 Feb;92(2):169-180. doi: 10.1007/s00115-020-01048-y. Nervenarzt. 2021. PMID: 33523263 Review. German.

4

[Irreversible loss of brain function-Part 1: pitfalls in clinical diagnosis].

Janzen RWC, Lambeck J, Niesen WD, Erbguth F. Janzen RWC, et al. Nervenarzt. 2020 Aug;91(8):743-757. doi: 10.1007/s00115-020-00952-7. Nervenarzt. 2020. PMID: 32705299 German.

5

Coma and cerebral imaging.

Haupt WF, Hansen HC, Janzen RW, Firsching R, Galldiks N. Haupt WF, et al. Among authors: janzen rw. Springerplus. 2015 Apr 16;4:180. doi: 10.1186/s40064-015-0869-y. eCollection 2015. Springerplus. 2015. PMID: 25984436 Free PMC article.

6

Non-necrotizing autoimmune myopathy with pipestem type capillaries - a light and electron microscopic study.

Janzen RW, Weber M, Schlote W. Janzen RW, et al. Clin Neuropathol. 2012 Mar-Apr;31(2):81-6. doi: 10.5414/np300395. Clin Neuropathol. 2012. PMID: 22385789

7

[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Janzen RW, Ludwig WD; Arzneimittelkommission der deutschen Ärzteschaft, Berlin. Janzen RW, et al. Z Rheumatol. 2012 Feb;71(2):108-10, 112-8. doi: 10.1007/s00393-011-0901-8. Z Rheumatol. 2012. PMID: 22370801 Review. German.

8

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

9

[Long-term treatment of refractory myasthenia gravis with immunoadsorption].

Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R, Grützmacher PW. Wagner S, et al. Among authors: janzen rw. Dtsch Med Wochenschr. 2008 Nov;133(46):2377-82. doi: 10.1055/s-0028-1100928. Epub 2008 Nov 4. Dtsch Med Wochenschr. 2008. PMID: 18988129 German.

10

Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR).

Heuschmann PU, Biegler MK, Busse O, Elsner S, Grau A, Hasenbein U, Hermanek P, Janzen RW, Kolominsky-Rabas PL, Kraywinkel K, Lowitzsch K, Misselwitz B, Nabavi DG, Otten K, Pientka L, von Reutern GM, Ringelstein EB, Sander D, Wagner M, Berger K. Heuschmann PU, et al. Among authors: janzen rw. Stroke. 2006 Oct;37(10):2573-8. doi: 10.1161/01.STR.0000241086.92084.c0. Epub 2006 Sep 7. Stroke. 2006. PMID: 16960092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page